Cited by 153Bacterial Cancer TherapyAmino Acid Enzymes and MetabolismPancreatic and Hepatic Oncology Research

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase

Open access

Bowles, Tawnya L., Kim, Randie, Galante, Joseph, Parsons, Colin M., Virudachalam, Subbulakshmi, Kung, Hsing‐Jien, Bold, Richard J.·2008·International Journal of Cancer

DOI 10.1002/ijc.23723PMC PMC4294549

Open this paper in CoChat — free account Open PDF

Abstract

Eukaryotic cells can synthesize the non-essential amino acid arginine from aspartate and citrulline using the enzyme argininosuccinate synthetase (ASS). It has been observed that ASS is underexpressed in various types of cancers ASS, for which arginine become auxotrophic. Arginine deiminase (ADI) is a prokaryotic enzyme that metabolizes arginine to citrulline and has been found to inhibit melanoma and hepatoma cancer cells deficient of ASS. We tested the hypothesis that pancreatic cancers have low ASS expression and therefore arginine deprivation by ADI will inhibit cell growth. ASS expression was examined in 47 malignant and 20 non-neoplastic pancreatic tissues as well as a panel of human pancreatic cancer cell lines. Arginine deprivation was achieved by treatment with a recombinant form of ADI formulated with polyethylene glycol (PEG-ADI). Effects on caspase activation, cell growth and cell death were examined. Furthermore, the effect of PEG-ADI on the in vivo growth of pancreatic xenografts was examined. Eighty-seven percent of the tumors lacked ASS expression; 5 of 7 cell lines similarly lacked ASS expression. PEG-ADI specifically inhibited growth of those cell lines lacking ASS. PEG-ADI treatment induced caspase activation and induction of apoptosis. PEG-ADI was well tolerated in mice despite complete elimination of plasma arginine; tumor growth was inhibited by approximately 50%. Reduced expression of ASS occurs in pancreatic cancer and predicts sensitivity to arginine deprivation achieved by PEG-ADI treatment. Therefore, these findings suggest that arginine deprivation by ADI could provide a beneficial strategy for the treatment of pancreatic cancer, a malignancy in which new therapy is desperately needed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/ijc.23723

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Autophagy as a Regulated Pathway of Cellular Degradation
Klionsky, D. J., & Emr, S. D. (2000) · Science · doi:10.1126/science.290.5497.1717 · Cited by 3,630
Autophagy: from phenomenology to molecular understanding in less than a decade
Klionsky, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2245 · Cited by 1,977
Autophagy as a cell death and tumor suppressor mechanism
Gözüaçık, D., & Kimchi, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207521 · Cited by 1,396
Another way to die: autophagic programmed cell death
Tsujimoto, Y., & Shimizu, S. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401777 · Cited by 765
Almost all about citrulline in mammals
Curis, E., Nicolis, I., Moinard, C., Osowska, S., Zerrouk, N., Bénazeth, S., & Cynober, L. (2005) · Amino Acids · doi:10.1007/s00726-005-0235-4 · Cited by 571
Autophagy delays apoptotic death in breast cancer cells following DNA damage
Abedin, M. J., Wang, D.-P., McDonnell, M. A., Lehmann, U., & Kelekar, A. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402039 · Cited by 532
The Roles of Therapy-Induced Autophagy and Necrosis in Cancer Treatment
Amaravadi, R. K., & Thompson, C. B. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1595 · Cited by 474
Enzymes of Arginine Metabolism
Morris, S. M. (2004) · Journal of Nutrition · doi:10.1093/jn/134.10.2743s · Cited by 361
Argininosuccinate synthetase from the urea cycle to the citrulline–NO cycle
Husson, A., Brasse‐Lagnel, C., Fairand, A., Renouf, S., & Lavoinne, A. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03559.x · Cited by 335
Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo.
Ensor, M., Holtsberg, F. W., Bomalaski, J. S., & Clark, M. A. (2002) · PubMed · Cited by 315

Show all 44 references

Sorted by citations

The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926
Metabolic Interactions in the Tumor Microenvironment
Lyssiotis, C. A., & Kimmelman, A. C. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.06.003 · Cited by 853
Arginase: an emerging key player in the mammalian immune system
Munder, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00291.x · Cited by 725
Amino acid metabolism in health and disease
Ling, Z., Jiang, Y.-F., Ru, J.-N., Lu, J.-H., Ding, B., & Wu, J. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01569-3 · Cited by 590
Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer
Delage, B., Fennell, D. A., Nicholson, L., McNeish, I., Lemoine, N. R., Crook, T., & Szlosarek, P. W. (2010) · International Journal of Cancer · doi:10.1002/ijc.25202 · Cited by 441
Arginine Deiminase as a Novel Therapy for Prostate Cancer Induces Autophagy and Caspase-Independent Apoptosis
Kim, R. H., Coates, J. M., Bowles, T. L., McNerney, G. P., Sutcliffe-Goulden, J., Jung, J. U., Gandour‐Edwards, R. F., Chuang, F. Y. S., Bold, R. J., & Kung, H.-J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3157 · Cited by 321
Self-citation
Arginine Signaling and Cancer Metabolism
Chen, C., Hsu, S.-C., Ann, D. K., Yen, Y., & Kung, H.-J. (2021) · Cancers · doi:10.3390/cancers13143541 · Cited by 276
Self-citation
Arginine dependence of tumor cells: targeting a chink in cancer’s armor
Patil, M. D., Bhaumik, J., Babykutty, S., Banerjee, U. C., & Fukumura, D. (2016) · Oncogene · doi:10.1038/onc.2016.37 · Cited by 272
Metabolic rearrangements in primary liver cancers: cause and consequences
Satriano, L., Lewińska, M., Rodrigues, P. M., Bañales, J. M., & Andersen, J. B. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0217-8 · Cited by 245
Targeting arginine-dependent cancers with arginine-degrading enzymes: opportunities and challenges
Phillips, M. M., Sheaff, M. T., & Szlosarek, P. W. (2013) · Cancer Research and Treatment · doi:10.4143/crt.2013.45.4.251 · Cited by 229
Arginine Starvation Impairs Mitochondrial Respiratory Function in ASS1-Deficient Breast Cancer Cells
Qiu, F., Chen, Y.-R., Liu, X., Chu, C.-Y., Shen, L., Xu, J., Gaur, S., Forman, H. J., Zhang, H., Zheng, S. S., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2004761 · Cited by 221
Self-citation
Metabolic reprogramming in renal cancer: Events of a metabolic disease
Chakraborty, S., Balan, M., Sabarwal, A., Choueiri, T. K., & Pal, S. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188559 · Cited by 214
Arginine starvation-associated atypical cellular death involves mitochondrial dysfunction, nuclear DNA leakage, and chromatin autophagy
Changou, C. A., Chen, Y.-R., Xing, L., Yen, Y., Chuang, F. Y. S., Cheng, R. H., Bold, R. J., Ann, D. K., & Kung, H.-J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1404171111 · Cited by 188
Self-citation
Phase II Study of Pegylated Arginine Deiminase for Nonresectable and Metastatic Hepatocellular Carcinoma
Glazer, E. S., Piccirillo, M., Albino, V., Giacomo, R. D., Palaia, R., Mastro, A. A., Beneduce, G., Castello, G., Rosa, V. D., Petrillo, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.7765 · Cited by 187
Arginine—Dual roles as an onconutrient and immunonutrient
Albaugh, V. L., Pinzon‐Guzman, C., & Barbul, A. (2016) · Journal of Surgical Oncology · doi:10.1002/jso.24490 · Cited by 173
Drug-induced amino acid deprivation as strategy for cancer therapy
Fung, M. K. L., & Chan, G. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0509-9 · Cited by 172
Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma
Syed, N., Langer, J., Janczar, K., Singh, P., Nigro, C. L., Lattanzio, L., Coley, H. M., Hatzimichael, E. C., Bomalaski, J. S., Szlosarek, P. W., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2012.197 · Cited by 167
A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients
Yang, T., Lu, S., Chao, Y., Sheen, I.-S., Lin, C.-C., Wang, T., Chen, S.-C., Wang, J., Liao, L.-Y., Thomson, J. A., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605856 · Cited by 160
Arginine metabolism and deprivation in cancer therapy
Zou, S., Wang, X., Liu, P., Ke, C., & Xu, S. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109210 · Cited by 165
Targeting arginine metabolism pathway to treat arginine-dependent cancers
Qiu, F., Huang, J., & Sui, M. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.04.020 · Cited by 158
Mechanisms of T-Cell Exhaustion in Pancreatic Cancer
Saka, D., Gökalp, M., Piyade, B., Çevik, N. C., Sever, E. A., Unutmaz, D., Ceyhan, G. O., Demir, İ. E., & Asimgil, H. (2020) · Cancers · doi:10.3390/cancers12082274 · Cited by 160
Metabolic pathways of L-arginine and therapeutic consequences in tumors
Szefel, J., Danielak, A., & Kruszewski, W. J. (2018) · Advances in Medical Sciences · doi:10.1016/j.advms.2018.08.018 · Cited by 158
Arginine Metabolism in Bacterial Pathogenesis and Cancer Therapy
Xiong, L., Teng, J. L. L., Botelho, M. G., Lo, R. C., Lau, S. K. P., & Woo, P. C. Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030363 · Cited by 157
The metabolic advantage of tumor cells
Israël, M., & Schwartz, L. H. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-70 · Cited by 130
Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1–Deficient Thoracic Cancers
Beddowes, E. J., Spicer, J. F., Chan, P. Y., Khadeir, R. S., Corbacho, J. G., Repana, D., Steele, J. P. C., Schmid, P., Szyszko, T. A., Cook, G., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.3230 · Cited by 121
Reduced Argininosuccinate Synthetase Is a Predictive Biomarker for the Development of Pulmonary Metastasis in Patients with Osteosarcoma
Kobayashi, E., Masuda, M., Nakayama, R. T., Ichikawa, H., Satow, R., Shitashige, M., Honda, K., Yamaguchi, U., Shoji, A., Tochigi, N., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0774 · Cited by 122
Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase
Kelly, M. P., Jungbluth, A. A., Wu, B.-W., Bomalaski, J. S., Old, L. J., & Ritter, G. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.524 · Cited by 117
Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase
Feun, L. G., Marini, A., Walker, G., Elgart, G., Moffat, F., Rodgers, S. E., Wu, C. J., You, M., Wangpaichitr, M., Kuo, M. T., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.106 · Cited by 113
Recombinant human arginase inhibits the in vitro and in vivo proliferation of human melanoma by inducing cell cycle arrest and apoptosis
Lam, A. T., Wong, G., Chow, H., Chong, H.-C., Chow, T. L., Kwok, S.-Y., Cheng, P. N.-M., Wheatley, D. N., Lo, W., & Leung, Y. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00798.x · Cited by 99
Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes
Kuo, M. T., Savaraj, N., & Feun, L. G. (2010) · Oncotarget · doi:10.18632/oncotarget.135 · Cited by 100
A metabolic synthetic lethal strategy with arginine deprivation and chloroquine leads to cell death in ASS1-deficient sarcomas
Bean, G. R., Kremer, J. C., Prudner, B. C., Schenone, A. D., Yao, J.-C., Schultze, M., Chen, D. Y., Tanas, M. R., Adkins, D. R., Bomalaski, J. S., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.232 · Cited by 103
Amino acid deprivation using enzymes as a targeted therapy for cancer and viral infections
Fernandes, H. S., Teixeira, C. S. S., Fernandes, P. A., Ramos, M. J., & Cerqueira, N. M. F. S. A. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1254194 · Cited by 91
Arginine-Depleting Enzymes – An Increasingly Recognized Treatment Strategy for Therapy-Refractory Malignancies
Riess, C., Shokraie, F., Classen, C. F., Kreikemeyer, B., Fiedler, T., Junghanß, C., & Maletzki, C. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495382 · Cited by 88
Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest
Lam, T. L., Wong, G., Chong, H.-C., Cheng, P. N.-M., Choi, S. C., Chow, T. L., Kwok, S.-Y., Poon, R. T. P., Wheatley, D. N., Lo, W., et al. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.11.031 · Cited by 87
Targeting extracellular nutrient dependencies of cancer cells
García‐Bermúdez, J., Williams, R. T., Guarecuco, R., & Birsoy, K. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.11.011 · Cited by 93
Spatial Transcriptomic and Metabolomic Landscapes of Oral Submucous Fibrosis‐Derived Oral Squamous Cell Carcinoma and its Tumor Microenvironment
Zhi, Y., Wang, Q., Zi, M., Zhang, S., Ge, J., Liu, K., Lu, L., Fan, C., Yan, Q., Shi, L., et al. (2024) · Advanced Science · doi:10.1002/advs.202306515 · Cited by 99
Overexpression of Arginine Transporter CAT-1 Is Associated with Accumulation of L-Arginine and Cell Growth in Human Colorectal Cancer Tissue
Lü, Y., Wang, W., Wang, J., Yang, C., Mao, H.-M., Fu, X., Wu, Y., Cai, J., Han, J., Xu, Z., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073866 · Cited by 81
Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinoma
Yau, T. C. C., Cheng, P., Chan, P., Chen, L., Yuen, J. H. F., Pang, R. W. C., Fan, S. T., Wheatley, D. N., & Poon, R. T. P. (2015) · Investigational New Drugs · doi:10.1007/s10637-014-0200-8 · Cited by 79
A phase 1/1B trial of ADI‐PEG 20 plus nab‐paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma
Lowery, M. A., Yu, K. H., Kelsen, D. P., Harding, J. J., Bomalaski, J. S., Glassman, D. C., Covington, C. M., Brenner, R., Hollywood, E. M., Barba, A., et al. (2017) · Cancer · doi:10.1002/cncr.30897 · Cited by 79
Discriminating gastric cancer and gastric ulcer using human plasma amino acid metabolic profile
Jing, F., Hu, X., Cao, Y., Xu, M., Wang, Y., Jing, Y., Hu, X., Gao, Y., & Zhu, Z. (2018) · IUBMB Life · doi:10.1002/iub.1748 · Cited by 72
Reprogramming of Amino Acid Metabolism in Pancreatic Cancer: Recent Advances and Therapeutic Strategies
Xu, R., Yang, J., Ren, B., Wang, H., Yang, G., Chen, Y., You, L., & Zhao, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.572722 · Cited by 74
Down-regulation of argininosuccinate synthetase is associated with cisplatin resistance in hepatocellular carcinoma cell lines: implications for PEGylated arginine deiminase combination therapy
McAlpine, J. A., Lu, H.-T., Wu, K. C., Knowles, S. K., & Thomson, J. A. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-621 · Cited by 67
Bioengineered Human Arginase I with Enhanced Activity and Stability Controls Hepatocellular and Pancreatic Carcinoma Xenografts
Glazer, E. S., Stone, E. M., Zhu, C., Massey, K. L., Hamir, A. N., & Curley, S. A. (2011) · Translational Oncology · doi:10.1593/tlo.10265 · Cited by 67
Blocking autophagy enhanced cytotoxicity induced by recombinant human arginase in triple-negative breast cancer cells
Wang, Z., Shi, X., Li, Y., Fan, J., Zeng, X. L., Xian, Z., Wang, Z., Sun, Y., Wang, S., Song, P., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.503 · Cited by 67
Arginine Starvation and Docetaxel Induce c-Myc–Driven hENT1 Surface Expression to Overcome Gemcitabine Resistance in ASS1-Negative Tumors
Prudner, B. C., Rathore, R., Robinson, A. M., Godec, A., Chang, S. F., Hawkins, W. G., Hirbe, A. C., & Tine, B. A. V. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0206 · Cited by 66
Polyamine Homeostasis in Development and Disease
Nakanishi, S., & Cleveland, J. L. (2021) · Medical Sciences · doi:10.3390/medsci9020028 · Cited by 68
Deciphering metabolic rewiring in breast cancer subtypes
Ogrodzinski, M. P., Bernard, J. J., & Lunt, S. Y. (2017) · Translational research · doi:10.1016/j.trsl.2017.07.004 · Cited by 67
Eutrophication and the dietary promotion of sea turtle tumors
Houtan, K. S. V., Smith, C. M., Dailer, M. L., & Kawachi, M. S. (2014) · PeerJ · doi:10.7717/peerj.602 · Cited by 62
Arginine: Challenges and opportunities of this two-faced molecule in cancer therapy
Jahani, M., Noroznezhad, F., & Mansouri, K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.109 · Cited by 61
Purification, immobilization, and biochemical characterization of l ‐arginine deiminase from thermophilic Aspergillus fumigatus KJ 434941: Anticancer activity in vitro
El‐Sayed, A. S. A., Hassan, M. N., & Nada, H. S. (2015) · Biotechnology Progress · doi:10.1002/btpr.2045 · Cited by 57
Efficacy of arginine depletion by ADI-PEG20 in an intracranial model of GBM
Przystal, J. M., Hajji, N., Khozoie, C., Renziehausen, A., Zeng, Q., Abaitua, F., Hajitou, A., Suwan, K., Want, E. J., Bomalaski, J. S., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1195-4 · Cited by 57
Arginine metabolism: a potential target in pancreatic cancer therapy
Yang, J., Wang, C., Qiu, J., Ren, B., & You, L. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001216 · Cited by 56
The why and how of amino acid analytics in cancer diagnostics and therapy
Manig, F., Kuhne, K., von Neubeck, C., Schwarzenbolz, U., Yu, Z., Kessler, B. M., Pietzsch, J., & Kunz‐Schughart, L. A. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.12.001 · Cited by 55
Engineering Reduced-Immunogenicity Enzymes for Amino Acid Depletion Therapy in Cancer
Cantor, J. R., Panayiotou, V., Agnello, G., Georgiou, G., & Stone, E. M. (2011) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-416039-2.00015-x · Cited by 53
Arginine deprivation affects glioblastoma cell adhesion, invasiveness and actin cytoskeleton organization by impairment of β-actin arginylation
Pavlyk, I., Rzhepetskyy, Y., Jagielski, A. K., Drożak, J., Wasik, A., Pereverzieva, G., Brewińska‐Olchowik, M., Kunz‐Schughart, L. A., Stasyk, O. V., & Rędowicz, M. J. (2014) · Amino Acids · doi:10.1007/s00726-014-1857-1 · Cited by 50
Arginine deprivation inhibits pancreatic cancer cell migration, invasion and EMT via the down regulation of Snail, Slug, Twist, and MMP1/9
Wang, H., Li, Q., Chow, H. Y., Choi, S., & Leung, Y.-C. (2019) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-019-00716-1 · Cited by 50
Amino Acid Degrading Enzymes and their Application in Cancer Therapy
Pokrovsky, V. S., Chepikova, O. E., Давыдов, Д. Ж., Zamyatnin, A. A., Lukashev, A. N., & Lukasheva, E. V. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666171006132729 · Cited by 50
Single amino acid arginine starvation efficiently sensitizes cancer cells to canavanine treatment and irradiation
Vynnytska‐Myronovska, B., Bobak, Y. P., Garbe, Y., Dittfeld, C., Stasyk, O. V., & Kunz‐Schughart, L. A. (2011) · International Journal of Cancer · doi:10.1002/ijc.26221 · Cited by 48
Argininosuccinate lyase is a potential therapeutic target in breast cancer
Huang, H.-L., Chen, W.-C., Hsu, H., Cho, C.-Y., Hung, Y.-H., Wang, C., & Lai, M.-D. (2015) · Oncology Reports · doi:10.3892/or.2015.4280 · Cited by 49
The role of arginine and the modified arginine deiminase enzyme ADI-PEG 20 in cancer therapy with special emphasis on Phase I/II clinical trials
Synakiewicz, A., Stachowicz‐Stencel, T., & Adamkiewicz‐Drożyńska, E. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.934808 · Cited by 45
Pegylated arginine deiminase synergistically increases the cytotoxicity of gemcitabine in human pancreatic cancer
Daylami, R., Muilenburg, D. J., Virudachalam, S., & Bold, R. J. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/preaccept-8245834981349245 · Cited by 43
Self-citation
Unlocking the Potential of Arginine Deprivation Therapy: Recent Breakthroughs and Promising Future for Cancer Treatment
Chu, Y., Lai, M., & Yeh, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310668 · Cited by 44
Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signaling
Liu, J., Ma, J., Wu, Z., Li, W., Zhang, D., Han, L., Wang, F., Reindl, K. M., Wu, E., & Ma, Q. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-686 · Cited by 41
Pan‐cancer RNA‐seq data stratifies tumours by some hallmarks of cancer
Frost, F. G., Cherukuri, P. F., Milanovich, S. J., & Boerkoel, C. F. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14746 · Cited by 42
Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase–Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic Type
Ji, J. X. Y., Cochrane, D. R., Tessier‐Cloutier, B., Chen, S. Y., Ho, G., Pathak, K. V., Alcazar, I. N., Farnell, D., Leung, S. C. Y., Cheng, A. S., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1905 · Cited by 42
Arginine deprivation as a new treatment strategy for head and neck cancer
Huang, C., Tsai, S., Kuo, C., Chang, J. S.-M., Jin, Y., Chang, J., & Hsiao, J. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2012.06.004 · Cited by 41
Exploiting Arginine Auxotrophy with Pegylated Arginine Deiminase (ADI-PEG20) to Sensitize Pancreatic Cancer to Radiotherapy via Metabolic Dysregulation
Singh, P. K., Deorukhkar, A., Venkatesulu, B. P., Li, X., Tailor, R. C., Bomalaski, J. S., & Krishnan, S. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0708 · Cited by 39
MicroRNA-1291-5p Sensitizes Pancreatic Carcinoma Cells to Arginine Deprivation and Chemotherapy through the Regulation of Arginolysis and Glycolysis
Tu, M., Duan, Z., Liu, Z., Zhang, C., Bold, R. J., Gonzalez, F. J., Kim, E. J.-H., & Yu, A. (2020) · Molecular Pharmacology · doi:10.1124/molpharm.120.000130 · Cited by 35
Self-citation
Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinoma
Liu, Q., Stewart, J., Wang, H., Rashid, A., Zhao, J., Katz, M. H. G., Lee, J. E., Fleming, J. B., Maitra, A., Wolff, R. A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171985 · Cited by 34
Metabolism remodeling in pancreatic ductal adenocarcinoma
Li, J., Wang, Y.-P., Yin, M., & Lei, Q. (2019) · Cell Stress · doi:10.15698/cst2019.12.205 · Cited by 37
Bench-to-Bedside Studies of Arginine Deprivation in Cancer
Field, G., Pavlyk, I., & Szlosarek, P. W. (2023) · Molecules · doi:10.3390/molecules28052150 · Cited by 34
Cytotoxicity of human recombinant arginase I (Co)-PEG5000 in the presence of supplemental L-citrulline is dependent on decreased argininosuccinate synthetase expression in human cells
Agrawal, V., Woo, J. H., Mauldin, J., Jo, C., Stone, E. M., Georgiou, G., & Frankel, A. E. (2011) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32834ae42b · Cited by 34
L-Canavanine potentiates the cytotoxicity of doxorubicin and cisplatin in arginine deprived human cancer cells
Nurcahyanti, A. D., & Wink, M. (2016) · PeerJ · doi:10.7717/peerj.1542 · Cited by 34
Connecting the Human Microbiome and Pancreatic Cancer
Sexton, R. E., Uddin, M. H., Bannoura, S. F., Khan, H. Y., Mzannar, Y., Li, Y., Aboukameel, A., Al-Hallak, M. N., Al-Share, B. A., Mohamed, A., et al. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10022-w · Cited by 33
Increased expression of argininosuccinate synthetase protein predicts poor prognosis in human gastric cancer
Shan, Y., Hsu, H., Lai, M.-D., Yen, M., LUO, Y.-P., & Chen, Y. (2014) · Oncology Reports · doi:10.3892/or.2014.3556 · Cited by 33
Argininosuccinate Synthetase 1 Loss in Invasive Bladder Cancer Regulates Survival through General Control Nonderepressible 2 Kinase–Mediated Eukaryotic Initiation Factor 2α Activity and Is Targetable by Pegylated Arginine Deiminase
Sahu, D., Gupta, S., Hau, A. M., Nakashima, K., Leivo, M. Z., Searles, S. C., Elson, P. J., Bomalaski, J. S., Casteel, D. E., Boss, G. R., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.09.004 · Cited by 32
Simultaneous determination of l-citrulline and l-arginine in plasma by high performance liquid chromatography
Mao, H.-M., Wei, W., Xiong, W., Lü, Y., Chen, B.-G., & Liu, Z. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.05.017 · Cited by 31
Arginine depriving enzymes: applications as emerging therapeutics in cancer treatment
Kumari, N., & Bansal, S. (2021) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-021-04335-w · Cited by 30
Metabolic rewiring of pancreatic ductal adenocarcinoma: New routes to follow within the maze
Olivares, O., & Vasseur, S. (2015) · International Journal of Cancer · doi:10.1002/ijc.29501 · Cited by 28
Overcoming Radiation Resistance in Gliomas by Targeting Metabolism and DNA Repair Pathways
Meng, W., Palmer, J. D., Siedow, M. R., Haque, S. J., & Chakravarti, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042246 · Cited by 34
Single Amino Acid Arginine Deprivation Triggers Prosurvival Autophagic Response in Ovarian Carcinoma SKOV3
Shuvayeva, G., Bobak, Y. P., Igumentseva, N. I., Titone, R., Morani, F., Stasyk, O. V., & Isidoro, C. (2014) · BioMed Research International · doi:10.1155/2014/505041 · Cited by 27
[HuArgI (co)-PEG5000]-induced arginine deprivation leads to autophagy dependent cell death in pancreatic cancer cells
Khalil, N., & Abi‐Habib, R. J. (2019) · Investigational New Drugs · doi:10.1007/s10637-019-00883-4 · Cited by 27
Microbial cancer therapeutics: A promising approach
Diwan, D., Cheng, L., Usmani, Z., Sharma, M., Holden, N. J., Willoughby, N. A., Sangwan, N. S., Baadhe, R. R., Liu, C., & Gupta, V. K. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.003 · Cited by 28
Yarrow supercritical extract exerts antitumoral properties by targeting lipid metabolism in pancreatic cancer
Mouhid, L., de Cedrón, M. G., García-Carrascosa, E., Reglero, G., Fornari, T., & de Molina, A. R. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214294 · Cited by 26
Arginine Metabolism in Cancer Biology and Immunotherapy
Bai, D., Zhou, Y., Jing, L., Guo, C., & Yang, Q. (2025) · Immune Network · doi:10.4110/in.2025.25.e30 · Cited by 27
Induction of arginosuccinate synthetase (ASS) expression affects the antiproliferative activity of arginine deiminase (ADI) in melanoma cells
Palmieri, G. (2011) · Oncology Reports · doi:10.3892/or.2011.1220 · Cited by 25
Dietary Manipulation of Amino Acids for Cancer Therapy
Jiménez‐Alonso, J. J., & López‐Lázaro, M. (2023) · Nutrients · doi:10.3390/nu15132879 · Cited by 26
Differential expression of argininosuccinate synthetase in serous and non‐serous ovarian carcinomas
Cheon, D., Walts, A. E., Beach, J. A., Lester, J., Bomalaski, J. S., Walsh, C., Wiedemeyer, W. R., Karlan, B. Y., & Oršulić, S. (2014) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.4 · Cited by 24
Insight into the interplay between mitochondria-regulated cell death and energetic metabolism in osteosarcoma
Lai, H.-T., Naumova, N., Marchais, A., Gaspar, N., Geoerger, B., & Brenner, C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.948097 · Cited by 23
Novel Mechanistic Insights into Arginine Deiminase Pharmacology Suggest 18F-FDG Is Not Suitable to Evaluate Clinical Response in Melanoma
Stelter, L., Evans, M. J., Jungbluth, A. A., ZANZONICO, P. B., Ritter, G., Ku, T. W., Rosenfeld, E., Bomalaski, J. S., Old, L. J., & Larson, S. M. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.092973 · Cited by 18
The trend toward more target therapy in pancreatic ductal adenocarcinoma
Deiana, C., Agostini, M., Brandi, G., & Giovannetti, E. (2024) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2024.2357802 · Cited by 17
Arginine Deprivation in SCLC: Mechanisms and Perspectives for Therapy
Carpentier, J., Pavlyk, I., Mukherjee, U., Hall, P. E., & Szlosarek, P. W. (2022) · Lung Cancer Targets and Therapy · doi:10.2147/lctt.s335117 · Cited by 16
Common alterations in plasma free amino acid profiles and gut microbiota-derived tryptophan metabolites of five types of cancer patients
Hussain, A., Xie, L., Deng, G., & Kang, X. (2023) · Amino Acids · doi:10.1007/s00726-023-03308-y · Cited by 16
Intracellular Delivery of Recombinant Arginine Deiminase (rADI) by Heparin-Binding Hemagglutinin Adhesion Peptide Restores Sensitivity in rADI-Resistant Cancer Cells
Wu, F. L., Yeh, T.-H., Chen, Y.-L., Chiu, Y.-C., Cheng, J.-C., Wei, M., & Shen, L. (2014) · Molecular Pharmaceutics · doi:10.1021/mp5001372 · Cited by 16
Rerouting the drug response: Overcoming metabolic adaptation in KRAS-mutant cancers
Moss, D., McCann, C. K., & Kerr, E. M. (2022) · Science Signaling · doi:10.1126/scisignal.abj3490 · Cited by 16
Pancreatic ductal adenocarcinoma in the era of precision medicine
Zheng-Lin, B., & O'Reilly, E. M. (2021) · Seminars in Oncology · doi:10.1053/j.seminoncol.2021.01.005 · Cited by 16
Arginine deiminase produced by lactic acid bacteria as a potent anti-cancer drug
Thakker, D. P., & Narayanan, R. (2023) · Medical Oncology · doi:10.1007/s12032-023-02043-4 · Cited by 14
Research progress on the role of cationic amino acid transporter (CAT) family members in malignant tumors and immune microenvironment
You, S., Han, X., Xu, Y., & Yao, Q. (2023) · Amino Acids · doi:10.1007/s00726-023-03313-1 · Cited by 14
Imaging of tumor vascularization using fluorescence molecular tomography to monitor arginine deiminase treatment in melanoma.
Stelter, L., Evans, M. J., Jungbluth, A. A., Longo, V. A., ZANZONICO, P. B., Ritter, G., Bomalaski, J. S., Old, L. J., & Larson, S. M. (2013) · PubMed · Cited by 14
Decreased argininosuccinate synthetase expression in Thai patients with cholangiocarcinoma and the effects of ADI‑PEG20 treatment in CCA cell lines
Roeksomtawin, S., Navasumrit, P., Waraprasit, S., Parnlob, V., Sricharunrat, T., Bhudhisawasdi, V., Savaraj, N., & Ruchirawat, M. (2018) · Oncology Letters · doi:10.3892/ol.2018.8807 · Cited by 14

Authors: Bowles, T. L., Kim, R., Galante, J., Parsons, C. M., Virudachalam, S., Kung, H., & Bold, R. J.
Affiliations: University of California Davis Medical Center (US)
Corresponding author: Bold, Richard J.
ORCID: Bowles, Tawnya L.
Kim, Randie
Galante, Joseph
Parsons, Colin M.
Kung, Hsing‐Jien
Bold, Richard J.
Venue: International Journal of Cancer
Publisher: Wiley
Published: 2008-08-13
Volume: 123
Issue: 8
Pages: 1950-1955
ISSN: 0020-7136 (ISSN-L)
1097-0215
DOI: 10.1002/ijc.23723
PMC: PMC4294549
OpenAlex: W2119097025
Cited by: 153
References: 44
Citations by year: 2026: 6 · 2025: 3 · 2024: 7 · 2023: 13 · 2022: 8 · 2021: 15 · 2020: 9 · 2019: 11 · 2018: 8 · 2017: 11 · 2016: 11 · 2015: 6 · 2014: 14 · 2013: 4 · 2012: 3
FWCI: 6.56
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: International Journal of Cancer (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Cancer Institute (P30CA093373)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK052659)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
Keywords: pancreatic cancer, argininosuccinate synthetase, arginine deprivation, arginine deiminase, arginine auxotrophy, apoptosis, caspase activation, tumor xenografts, arginine metabolism, cancer cell lines
MeSH terms: Animals, Arginine, Argininosuccinate Synthase, Humans, Hydrolases, Immunohistochemistry, Mice, Nude, Pancreatic Neoplasms, Polyethylene Glycols, RNA, Messenger, Apoptosis, Xenograft Model Antitumor Assays, Cell Growth Processes, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks